Abstract
Objective: The aim of this study was to evaluate the diagnostic performance of a multiparametric gadolinium ethoxybenzyl-diethylenetriaminepentaacetic acid (Gd-EOB-DTPA)-enhanced MRI examination for the estimation of liver dysfunction classified by the Model for End-Stage Liver Disease (MELD) score. Results: Liver dysfunction can be assessed by different methods. In a logistic regression analysis, T1- and T2-weighted images were affected by impaired liver function. In the assessment of liver dysfunction, the reduction rate in T1 mapping sequences showed a significant correlation in simple and multiple logistic regression. Conclusion: Changes in Gd-EOB-DTPA-enhanced MRI between plain images and images obtained during the hepatobiliary phase allowed good prediction of liver dysfunction, especially when using T1 mapping sequences. Materials and Methods: A total of 199 patients underwent contrast-enhanced MRI with a hepatocyte-specific contrast agent at 3T. In the multivariable analysis, the full range of available MRI sequences was used to estimate the liver dysfunction of patients with various MELD scores.
Author supplied keywords
Cite
CITATION STYLE
Verloh, N., Utpatel, K., Zeman, F., Fellner, C., Schlitt, H. J., Müller, M., … Haimerl, M. (2018). Diagnostic performance of Gd-EOB-DTPA-enhanced MRI for evaluation of liver dysfunction: A multivariable analysis of 3T MRI sequences. Oncotarget, 9(91), 36371–36378. https://doi.org/10.18632/oncotarget.26368
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.